VERTEX PHARMACEUTICALS INC's ticker is VRTX and the CUSIP is 92532F100. A total of 192 filers reported holding VERTEX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $98,197 | -10.8% | 365,522 | -13.3% | 0.58% | +26.6% |
| Q1 2022 | $110,071 | -46.0% | 421,775 | -54.6% | 0.46% | -25.6% |
| Q4 2021 | $203,963 | -34.2% | 928,791 | -45.7% | 0.62% | -17.2% |
| Q3 2021 | $310,132 | -13.3% | 1,709,751 | -3.6% | 0.74% | +11.9% |
| Q2 2021 | $357,705 | -3.2% | 1,774,066 | +3.2% | 0.67% | -9.3% |
| Q1 2021 | $369,406 | +91.5% | 1,719,046 | +110.6% | 0.73% | +43.1% |
| Q4 2020 | $192,899 | +628.2% | 816,194 | +738.4% | 0.51% | +226.8% |
| Q3 2020 | $26,491 | – | 97,352 | – | 0.16% | – |
Download | ||||||